Fig. 2From: Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort studyMACCE-free survival of the patients. a showed the overall MACCE-free survival of all patients; b showed the comparison of MACCE-free survival between AC group and AT group. (AC, aspirin plus clopidogrel; AT, aspirin plus ticagrelor; CI, confidence interval; MACCE, major adverse cardiovascular and cerebrovascular events; Pt., patients)Back to article page